Odyssey Therapeutics Inc (ODTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||
| Net Income | -38,262 | N/A | -38,435 |
| Depreciation Amortization | 1,171 | N/A | 1,299 |
| Accounts payable and accrued liabilities | 484 | N/A | 713 |
| Other Working Capital | -7,190 | N/A | -5,284 |
| Other Operating Activity | 2,762 | 0 | 3,086 |
| Operating Cash Flow | $-41,035 | $N/A | $-38,621 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -148 | N/A | -873 |
| Purchase Of Investment | 34,950 | N/A | 35,000 |
| Investing Cash Flow | $34,802 | $N/A | $34,127 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 651 | N/A | 235 |
| Other Financing Activity | -167 | 0 | -35 |
| Financing Cash Flow | $484 | $N/A | $200 |
| Exchange Rate Effect | 24 | N/A | 69 |
| Beginning Cash Position | 44,897 | N/A | 62,346 |
| End Cash Position | 39,172 | N/A | 58,121 |
| Net Cash Flow | $-5,725 | $N/A | $-4,225 |
| Free Cash Flow | |||
| Operating Cash Flow | -41,035 | N/A | -38,621 |
| Capital Expenditure | -148 | N/A | -927 |
| Free Cash Flow | -41,183 | 0 | -39,548 |